Louisiana 2016 Regular Session

Louisiana House Bill HB864

Introduced
3/4/16  
Introduced
3/4/16  
Refer
3/4/16  
Refer
3/4/16  
Refer
3/14/16  
Refer
3/14/16  
Report Pass
4/13/16  
Report Pass
4/13/16  
Engrossed
4/25/16  
Refer
4/26/16  
Refer
4/26/16  
Report Pass
5/4/16  
Report Pass
5/4/16  
Enrolled
5/11/16  
Enrolled
5/11/16  
Chaptered
5/19/16  

Caption

Prohibits certain claims fees assessed by health insurers or pharmacy benefit managers

Impact

This bill impacts state laws related to pharmacy operations and health insurance practices in Louisiana, aiming to enhance transparency and fairness in insurance transactions involving pharmacy benefits. By prohibiting undisclosed claims fees, the law seeks to prevent health insurers and pharmacy benefit managers from unfairly charging pharmacies for services without prior notice. This change is anticipated to lead to clearer financial dealings between pharmacies and insurers, ultimately benefiting consumers by promoting competitive pricing.

Summary

House Bill 864 is legislation enacted in Louisiana aimed at regulating the fees that health insurance issuers and pharmacy benefit managers can impose on pharmacies. Specifically, it prohibits the assessment of certain claims fees if they are not disclosed at the time of claim processing, are not included in the remittance advice following an adjudicated claim, or are imposed after the initial claim has been adjudicated. This law aims to protect pharmacists and pharmacies from unexpected financial burdens linked to the claims process.

Sentiment

The sentiment surrounding HB 864 is generally positive, particularly among pharmacies and advocates for healthcare transparency. Legislators supporting the bill viewed it as necessary to protect local businesses from unfair practices by insurance companies and improve the overall functioning of the healthcare system. The unanimous Senate vote in favor of the bill reflects a broad consensus about the need for reform in how pharmacy benefit management is conducted in the state.

Contention

Although there were no explicit points of contention noted in the discussions or voting history related to HB 864, the broader context reflects ongoing concerns about the ethical practices of pharmacy benefit managers and their impact on healthcare costs. The bill could be seen as a step towards greater oversight and accountability in the pharmacy benefits sector, which has faced scrutiny for practices that lead to increased costs for both healthcare providers and consumers.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.